Custom-Made immune cells target stubborn lung cancer
NCT ID NCT05676749
Summary
This early-stage study tested a personalized treatment for advanced lung cancer that had stopped responding to standard immunotherapy. Doctors collected a patient's own tumor-fighting immune cells, grew them in a lab, and reinfused them along with other immune-boosting drugs. The main goals were to check if this combination was safe and to see if it could shrink tumors in patients with few remaining options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Allegheny Health Network-West Penn Hospital
Pittsburgh, Pennsylvania, 15224, United States
-
Duke Center for Cancer Immunotherapy
Raleigh, North Carolina, 27710, United States
-
Ochsner MD Anderson Cancer Center
New Orleans, Louisiana, 70121, United States
Conditions
Explore the condition pages connected to this study.